No Obligation to Employ Clause Example from Business Contracts

2019 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on June 7, 2019)

2019 Equity Incentive Plan, and forms of award agreements (Filed With SEC on March 6, 2023)

2019 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on June 14, 2019)

2015 Equity Incentive Plan, as amended, and forms of award agreements thereunder (Filed With SEC on March 3, 2020)

2015 Equity Incentive Plan, as amended, and forms of award agreements thereunder (Filed With SEC on March 11, 2021)

PRONAI THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN (Filed With SEC on July 6, 2015)

2020 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on February 18, 2020)

2020 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on January 21, 2020)

2020 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on January 6, 2020)

Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on July 17, 2020)

2020 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on July 20, 2020)

2020 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on September 4, 2020)

2020 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on September 21, 2020)

2020 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on September 21, 2020)

2020 Equity Incentive Plan and form of award agreements (Filed With SEC on October 9, 2020)

Augmedix, Inc. 2020 Equity Incentive Plan, as amended and restated effective July 1, 2021 (Filed With SEC on July 8, 2021)

Amended and Restated 2016 Equity Incentive Plan and form award agreements thereunder (Filed With SEC on November 6, 2020)

OBALON THERAPEUTICS, INC. 2016 EQUITY INCENTIVE PLAN (Filed With SEC on September 26, 2016)

2021 Equity Incentive Plan and forms of award agreements thereunder (Filed With SEC on March 1, 2021)

2021 Equity Incentive Plan and forms of award agreements thereunder (Filed With SEC on March 23, 2021)

2021 Equity Incentive Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on June 21, 2021)

2021 Equity Incentive Plan, to become effective on the day immediately before the date of this prospectus, and forms of award agreements (Filed With SEC on October 13, 2021)

Allarity Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on December 6, 2021)

2021 Equity Incentive Plan (Filed With SEC on December 9, 2021)

2021 Equity Incentive Plan and form of Stock Bonus Award Agreement (Filed With SEC on December 23, 2021)

Form of 2022 Equity Incentive Plan (Filed With SEC on September 12, 2022)

Achieve Life Sciences 2018 Equity Incentive Plan, as amended, and forms of award agreements thereunder (Filed With SEC on March 16, 2023)

ACHIEVE LIFE SCIENCES, INC. 2018 EQUITY INCENTIVE PLAN (Filed With SEC on November 7, 2018)

Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on November 8, 2018)

AEGLEA BIOTHERAPEUTICS, INC. 2016 EQUITY INCENTIVE PLAN (Filed With SEC on March 28, 2016)

2014 Equity Incentive Plan, as amended April 23, 2018 and forms of award agreements (Filed With SEC on August 9, 2018)

LOXO ONCOLOGY, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on July 21, 2014)

2018 Equity Incentive Plan, to become effective on the date immediately prior to the date of this prospectus, and forms of award agreements thereunder (Filed With SEC on September 6, 2018)

2018 Equity Incentive Plan and form of agreements used thereunder (Filed With SEC on July 9, 2018)

2018 Equity Incentive Plan, to be effective on the date immediately prior to the effective date of this registration statement, and forms of award agreements (Filed With SEC on March 16, 2018)

ANAPTYSBIO, INC. 2017EQUITY INCENTIVE PLAN (Filed With SEC on January 17, 2017)

AUDENTES THERAPEUTICS, INC. 2016 EQUITY INCENTIVE PLAN (Filed With SEC on July 11, 2016)

LENDINGCLUB CORPORATION 2014 EQUITY INCENTIVE PLAN (Filed With SEC on December 1, 2014)

GOPRO, INC. 2014 EQUITYINCENTIVE PLAN (Filed With SEC on June 11, 2014)

TRUPANION, INC. 2014EQUITY INCENTIVE PLAN (Filed With SEC on June 16, 2014)

CORIUM INTERNATIONAL, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on March 24, 2014)

FITBIT, INC. 2015EQUITY INCENTIVE PLAN (Filed With SEC on May 7, 2015)

ADESTO TECHNOLOGIES CORPORATION 2015 EQUITY INCENTIVE PLAN (Filed With SEC on October 5, 2015)

DEXCOM, INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN (March 16, 2017) (Filed With SEC on August 1, 2017)

BIOPHARMX CORPORATION 2016 EQUITY INCENTIVE PLAN (adopted by the Board on February 10, 2017) (amended and restated on March 28, 2017) (Filed With SEC on April 21, 2017)